The increased incidence of minor physical anomalies (MPAs) in schizophrenia is the fundamental basis for the neurodevelopmental hypothesis of schizophrenia etiology. Ocular misalignment, or strabismus, falls into the category of MPAs, but this phenotype has not been assessed in schizophrenia. This study reveals that a subtype of strabismus, constant exotropia, displays marked association with schizophrenia (P ¼ 0.00000000906). To assess the genetic mechanisms, we examined the transcription factor genes ARIX (recently identified as a causative gene for syndromic strabismus) and its paralogue, PMX2B. We identified frequent deletion/insertion polymorphisms in the 20-alanine homopolymer stretch of PMX2B, with a modest association between these functional polymorphisms and constant exotropia in schizophrenia (P ¼ 0.029). The polymorphisms were also associated with overall schizophrenia (P ¼ 0.012) and more specifically with schizophrenia manifesting strabismus (P ¼ 0.004). These results suggest a possible interaction between PMX2B and other schizophrenia-precipitating factors, increasing the risk of the combined phenotypes. This study also highlights the unique nature of the polyalanine length variations found in PMX2B. In contrast with other transcription factor genes, the variations in PMX2B show a high prevalence, with deletions being more common than insertions. Additionally, the polymorphisms are of ancient origin and stably transmitted, with mild phenotypic effects. In summary, our study lends further support to the disruption of neurodevelopment in the etiology of schizophrenia, by demonstrating the association of a specific MPA, in this case, constant exotropia with schizophrenia, along with molecular variations in a possible causative gene.
INTRODUCTION
The view that neurodevelopmental abnormalities are involved in, at least partially, the etiologies of schizophrenia has become prevalent, as can be seen from a range of epidemiological, clinical and neurobiological evidence (1) . One facet of such supporting evidence is the observation of a significantly higher prevalence of minor physical anomalies (MPAs) in schizophrenic patients than in healthy controls (reviewed in 2). MPAs involve slight dysmorphic features representing subtle alterations in the development of various ectoderm-derived bodily structures in the mouth, eye, ear, global head, hand and foot areas. MPAs are believed to develop during the first and/or early second trimesters of gestation (3) . As the bodily structures involved in the expression of MPAs typically share an embryonic origin with that of the brain (4) , an organ of ectodermal origin, MPAs represent potentially valuable indices of disturbances in early neuronal development. MPAs may result from both genetic factors and environmental influences, such as complications during pregnancy (2) . The findings that MPAs are particularly common among schizophrenic patients with a family history of the disorder (5) , and that siblings display significantly more MPAs than normal subjects (6) represent evidence of a genetic effect.
MPAs in schizophrenia have been scored using the Waldrop scale (7), including modified versions (8) and additional or different items (9) . The Waldrop scale was originally devised for use in children with Down's syndrome, and is a standardized tool for assessing 18 features of the head, eyes, ears, mouth, hands and feet. However, the study of MPAs in schizophrenia is still in the exploratory phase, and the instruments used to measure MPAs have been criticized for their inherent limitations, including content. For eye assessments, the items that have been addressed thus far include telecanthus, epicanthus (7), heterochromia and ptosis (6) . Abnormalities in eye position, such as the presence of strabismus, have not been addressed in previous studies. Isolated nonsyndromic strabismus affects 1-5% of the general population (10) . Most forms of strabismus are multifactorial in origin, with possible inherited components. Strabismus can result from errors in developmental co-ordination of cranial nerves innervating the extraocular muscles, namely the oculomotor (nIII), trochlear (nIV) and abducens nerves (nVI). These cranial nerves differentiate from neural crest cells in the embryonic stage (11) . Once formed in the developmental stage, strabismus persists into adult life and is readily detected on simple visual examination, as with other MPAs. We therefore set out to compare the prevalence of strabismus in schizophrenia and mentally normal cohorts in this study, to determine whether this developmentally minor anomaly is associated with schizophrenia.
The genes responsible for strabismus have long remained quite unknown. However, Nakano et al. (12) recently reported homozygous mutations in ARIX (PHOX2A) in congenital fibrosis of the extraocular muscles type 2 (CFEOM2), which accompanies strabismus. The ARIX paralogue, PMX2B (PHOX2B) (12) , is 100% identical to ARIX within the homeodomain and 71% identical over the whole gene. The two proteins show an overlapping pattern of expression, including co-expression in the nIII and nIV cranial nerve nuclei (13) that control eye alignment. Both genes are also known to be involved in the development of catecholaminergic neurons (13) . We therefore screened for polymorphisms in these two candidate genes and evaluated the contribution of detected variants to risk of strabismus and schizophrenia.
RESULTS

Strabismus in schizophrenia and controls
Much of the difficulty in studying strabismus lies in the use of varying definitions and measures of strabismus (14) . For the purpose of the present study, strabismus was defined as ocular misalignment in which both eyes are not directed to the object of regard (for details see Materials and Methods). This includes both misalignment in the primary position (straight ahead gaze) and eccentric gaze. All subjects defined as displaying strabismus in this study manifested concomitant strabismus without any systemic abnormalities: angle of misalignment was approximately the same for all directions of gaze (i.e., none of the subjects demonstrated incomitant/paralytic strabismus). Concomitant strabismus is the most common form of ocular motility defect, and has been the target of numerous epidemiological studies (14) . The observed concomitant strabismus was divided into subtypes according to the direction of squint and based on whether the condition was constant or intermittent, as different mechanisms have been suggested for different forms of strabismus. The complication of strabismus as a whole displayed a highly significant association with schizophrenic cohorts compared to control subjects (P ¼ 0.0000161; Table 1 ). When subtypes of strabismus were inspected, this marked association was attributable to the over-representation of constant exotropia in schizophrenia (P ¼ 0.00000000906; Table 1 , Fig. 1 ). The odds ratio for constant exotropia in schizophrenia was 20.6 (95% confidence interval, 5.03-56.2). Age of onset of schizophrenia in cohorts with (mean AE SD, 24.4 AE 6.5 years) and without (mean AE SD, 26.1 AE 9.5 years) strabismus did not differ significantly (P ¼ 0.625 using the Mann-Whitney test).
Analyses of candidate genes
Strabismus is widely acknowledged as displaying genetic components, although the etiology is multifactorial (14) . Confirming this notion, disruption of ARIX protein, a homeodomain transcription factor, has recently been reported to cause strabismus as one symptom in CFEOM2 (12) . We therefore first examined ARIX in the 24 schizophrenic patients manifesting constant exotropia (Table 1) . However, no polymorphisms were detected.
As ARIX has a close paralogue, PMX2B, this gene was the next to be screened in the same samples. Human PMX2B (paired mesoderm homeobox 2b, also known as NBPhox) encodes a transcription factor with a paired-like homeodomain (15) . The chromosomal assignment of the gene was first reported to be 5p12-p13 (15) , but later amended to 4p12-13 by GenBank (accession no. AB015671). We further refined the location to 4p13, by fluorescence in situ hybridization using the BAC clone RP11-227F1910, which spans the PMX2B and by radiation hybrid mapping using the Stanford G3 panel (http:// shgc-www.stanford.edu/RH/index.html) (linked to SHGC4-435, LOD 13.6). The PMX2B protein contains two polyalanine regions, comprising nine (Ala9) and 20 alanines (Ala20), both located downstream of a homeobox domain, and none of which are present in ARIX (Fig. 2) . Interestingly, mutation screening detected variations in length of the Ala20 tract, with variant alleles derived from an in-frame deletion of alanine residues and an insertion. Examination of all schizophrenia (n ¼ 346) and control samples (n ¼ 542) revealed three different mutated alleles: À15 bp (À5 Ala), À21 bp (À7 Ala) and þ6 bp (þ2 Ala) (mutated alleles: 5.9% in schizophrenia, 4.8% in controls) (Figs 3 and 4) . Initial analysis using ordinal denaturing acrylamide gels detected bands migrating to a À3 base position (Fig. 5) breakdown hydrogen bonds in the highly GC template revealed that the 3-base shift was induced by a c.762A-to-C substitution (Ala254Ala) (Figs 2 and 5). We also observed that the alleles having both 15 bp deletion and c.762C migrated at a À18 base position. All the alleles with 21 bp deletion and 6 bp insertion displayed c.762A. Deletion/insertion polymorphisms of PMX2B were in HardyWeinberg equilibrium in all sample groups, and displayed a modest association with constant exotropia in the schizophrenic group [nominal P ¼ 0.029 by 2 Â 4 Fisher's exact test; P-value after Bonferroni correction is not significant, when multiple tests for three-way comparisons (Table 2 ) plus threeway comparisons (Table 3) are considered] and in the combined samples (schizophrenia þ controls) (nominal P ¼ 0.017), but not in controls (P ¼ 1.000) ( Table 2 ). In schizophrenia, the deleted allele (À15 bp) was over-represented in subjects with constant exotropia. The polymorphisms were weakly associated with overall schizophrenia (nominal P ¼ 0.012), and more specifically with the subset of schizophrenia that carried constant exotropia (nominal P ¼ 0.004, corrected P ¼ 0.024) ( Table 3 ). Power analysis showed that the present sample size had powers of 0.757 and 0.912 (a < 0.05) in an additive model with a genotype relative risk of 1.5 and allele frequencies of 0.1 and 0.2, respectively.
The polyalanines affect the protein function
To understand the functional role of alanine repeats in PMX2B, we generated constructs with total deletion or varying length of the Ala20 sequence and total deletion of the Ala9 sequence (Fig. 6A ). Activities as transcription factors under the dopamine b-hydroxylase gene (DBH) promoter were then examined. Deletion of Ala20 or Ala9 sequences reduced luciferase activity to approximately half the normal PMX2B value (Fig. 6B) . Deletion of Ala20 produced a larger reduction than deletion of Ala9. Increasing [þ5 alanine residues (16)] or decreasing (À1, À5, À6, À7, or À13 alanine residues: we found one schizophrenic patient with a À13 alanine deletion who was unavailable for ophthalmologic examination) the Ala20 stretch also reduced promoter activity, with the greatest change seen in the þ5 alanine insertion (16) (Fig. 6C) .
During the preparation of our manuscript, Amiel et al. (16) reported an association between CCHS and variants with þ5 to þ9 alanine expansions within the Ala20 tract of PMX2B. In some of their patients, expansions resulted from de novo mutations, prompting Amiel et al. to suggest unequal crossingover during meiosis as a mechanism for the mutations (16) . In the separate panel of family samples, we analyzed allele transmission, but found no evidence of de novo mutations (transmitted alleles included 259 wild-type and 15 deleted variants). If the polymorphisms detected in this study were attributable to unequal crossing-over, the area surrounding the Ala20 stretch should represent a recombination hot spot, giving rise to an LD gap in this region. Mutation screening and a database search identified nine SNPs in the genomic region surrounding the Ala20 stretch (Fig. 1) . LD analysis between these SNPs excluded the possibility of an LD gap (Table 4) . Furthermore, analysis of the evolutionary history of haplotypes defined by these SNPs and alanine length variations suggested a relatively ancient origin for polymorphisms of the Ala20 stretch (Fig. 7) . The amino acid sequence of human PMX2B differs from that seen in mouse (17) by one residue located outside either polyalanine stretch. Orthologous genes in other species have not been reported. We examined the Ala20 homopolymer in mouse Pmx2b from each of the parental lines C57BL/6 and C3H/He, in addition to F1 intercrosses (n ¼ 120 each), and found no polymorphisms. These results imply that the Ala20 stretch (and the genetic variations in humans) is stably transmitted in both species. However, this stability of transmission differs from the duplications seen in the rare CCHS (16) .
DISCUSSION
This is the first study to report the frequency of strabismus, an ocular misalignment, in schizophrenia. Constant exotropia, a subtype of strabismus, was found to be extremely prevalent in schizophrenia compared to normal controls. In addition, the rate of overall strabismus (13%) or constant exotropia (6.9%) in our schizophrenic cases was higher than that of ptosis (2%) (6), another MPA of the eye. We therefore propose that strabismus (more specifically, constant exotropia) should be considered in the item list for MPAs that are assessed in schizophrenia from the perspective of neurodevelopmental etiology. Some researchers have reported rare cases of schizophrenia exhibiting temporal strabismus affected by psychotic state (18, 19) . None of our cases displayed this type of 'fluctuating' strabismus. All current schizophrenic patients in this study were maintained on the appropriate medication. Neuroleptics are known to sometimes cause acute dystonic reactions, and involvement of the extraocular muscles may result in oculogyric crisis, wherein the eyes are elevated and 'locked' in this position (20) . However, this symptom is easily differentiated from strabismus in the clinical situation.
The reason for accumulation of this specific subtype of strabismus (constant exotropia) in schizophrenia is unknown. Comitant strabismus is likely to display an etiologically heterogenous, complex and multifactroial phenotype, possibly with genetically distinct backgrounds according to subtype (reviewed in 14). For instance, Schlossman and Priestley (21) reported the presence of a family history in 50% of esotropes and 37% of exotropes. Direction of squint in each family was concordant with that of the affected proband. Waardenburg (22) described families in which exotropia was transmitted through generations, implying dominant transmission. Maumenee and Alston (23) described inheritance of congenital esotropia. Our results suggest an overlap of genetic etiology and developmental trigger for constant exotropia and schizophrenia.
Prevalences of the various forms of concomitant strabismus vary widely among populations. Gover and Yankey (24) found prevalences of 2.5 and 0.6% for strabismus among Caucasians and African Americans, respectively; most of the latter were exotropic. Nordlow (25) examined a Caucasian population, finding prevalences of 2.59% constant esotropes, 0.93% (Table 4) . Amino acid residues flanking Ala20 are also denoted.
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intermittent esotropes, 0.13% constant exotropes, 0.3% intermittent exotropes and 0.05% hypertropes, for a total of 4% strabismics. Laatikainen and Erkkila (26) reported 2.9% esotropes and 1.7% exotropes in a study of 411 Finnish schoolchildren. Ing and Pang (27) reported the frequency in Asian populations, as 33% esotropia and 67% exotropia. Concordant with their Asian data, occurrence of exotropia (3.5%) is about 2-fold higher than that of esotropia in our Japanese controls (1.5%). Differences between races in the frequencies and types of strabismus may again be attributable to genetic factors, providing further evidence of a genetic contribution. We could not examine the heritability of strabismus in schizophrenia (and controls) in the present case-control study, because of a lack of information on the phenotypic status of parents and siblings, but this would be an important issue to be solved in future studies. Human PMX2B and its mouse ortholog are expressed in neural crest cell derivatives and play a primary role in the generation and survival of adrenergic neurons and a subpopulation of brainstem motor neurons (13) . PMX2B protein is expressed in the nIII and nIV cranial nerve nuclei (13) that control eye alignment. This expression pattern may explain the contribution of functional polymorphisms to the risk of strabismus in schizophrenia. However, PMX2B mutations alone may not be sufficient to induce strabismus, it may require interaction with an additional causative gene(s) and/or environmental factors relevant to schizophrenia, since the mutations were not associated with strabismus in normal subjects. PMX2B regulates the expression of tyrosine hydroxylase and DBH, which are required for the biosynthesis of dopamine and noradrenaline, respectively, in catecholaminergic cells (13) . Perturbations in the expression of these enzymes have been linked to the pathophysiology of schizophrenia (28) . In line with the pivotal roles of PMX2B in catecholaminergic neurons, variation of the Ala20 length in PMX2B sequence exerted a genetic effect, albeit modest, on the development of overall schizophrenia. A stronger association of PMX2B variation with the subset of schizophrenics who manifested constant exotropia suggests that Data on transcriptional activity suggest that even homozygote carriers of variant alanine homopolymer stretches may possess residual PMX2B function. This is consistent with the fact that Pmx2b heterozygous knockout mice are viable, with no reported abnormalities (29) . This may also account for the lack of robust association between schizophrenia and PMX2B Ala20 variations. In-frame expansions but not deletions of polyalanine stretches in transcription factors and homeodomain genes have been well documented, along with associated clinical traits, all of which are inherited in an autosomal dominant manner, as with CBFA1 (30), HOXA13 (31), HOXD13 (32), ZIC2 (33) and, as recently reported, PMX2B (16). All these mutations are rare, possibly resulting from de novo generation (and a mechanism of unequal crossing-over during meiosis), and result in profound phenotypic defects. The uniqueness of polyalanine length variations in PMX2B is thus interesting to consider in terms of commonness, more frequent deletion than insertion, all in the context of a historically ancient humanspecific origin with stable transmission and mild phenotypic effect. The relevance of polymorphisms in Ala20 in contrast to Ala9 of human PMX2B gene is unknown. Intriguingly, Ala20 in PMX2B is flanked by sequences rich in serine, glycine, proline (residues that could be generated by substitution of the first or second nucleotides within a progenitor alanine codon, GCX), and additional alanine residues (Fig. 1) , whereas Ala9 is not. The suggestion is that the current Ala20 stretch might have undergone dynamic evolutional change (34) .
In summary, MPAs have been found to display increased prevalence in a range of neurodevelopmental disorders other than schizophrenia, including learning disabilities, congenital speech, hearing impairments, attention deficit hyperactivity disorder (35) and autism (36) . Investigation of the prevalence of strabismus in those neuropsychiatric disorders, and assessment of the role of PMX2B variations in strabismus conveyed by these illnesses and in the development of the illnesses themselves may therefore prove worthwhile.
MATERIALS AND METHODS
Subjects
For ophthalmologic examinations, 346 schizophrenia (mean age 42.8AE 8.3 years) and 542 mentally healthy controls (mean age 42.5 AE 11.0 years) were recruited. All subjects were collected from a single geographic area in central Japan. Diagnosis of schizophrenia was achieved by direct interview, based on the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) (37), with consensus from at least three experienced psychiatrists. All available medical records were taken into consideration. All patients underwent computer tomography examination of the brain to exclude organic abnormalities. None of the current subjects displayed mental retardation or congenital central hypoventilation syndrome (CCHS) (16) . Control subjects were recruited from among volunteers documented as free of psychoses. A total of 124 families were recruited separately to test for transmission stability of PMX2B variants. These comprised 80 families with one offspring plus parents, 18 with two offspring plus parents and five with three offspring plus parents. Biological parentage in all families was confirmed by examining 444 highly polymorphic microsatellite markers from Japanese cohorts (mean heterozygosity ¼ 0.73) (38) . The present study was approved by the Ethics Committees of RIKEN and Hamamatsu Medical University, and all participants provided written informed consent.
Ophthalmologic examination
Clinical assessments were made by trained medical doctors (Tomoko Toyota, Yoshio Minabe and Kiyoshi Yoshitugu) in a blind study, and confirmed by an independent and experienced ophthalmologist (Hajime Fujikura). The Hirschberg test and two kinds of cover tests (a cover-uncover test and an alternating cover test) were conducted to detect and classify strabismus and to exclude heterophoria. None of the strabismus sufferers displayed incomitant strabismus, accommodation esotropia, or systemic abnormalities including developmental and metabolic defects, brain damage or mental retardation.
Mutation screening of ARIX and PMX2B
ARIX comprises three exons with the initiation codon in exon 1 and a stop codon in exon 3 (39) . We screened the coding region, flanking introns and promoter sequences (1210 bp upstream from the reported 5 0 end of exon 1) (39), using PCR amplification and sequencing of genomic DNA from 24 schizophrenia samples who showed constant exotropia (Table 1 ). Figure 4 . Fragment analysis of polymorphic Ala20 length genotypes. Four different Ala20 variants were detected: three in-frame deletions (À15, À21 and À39 bp) and one in-frame insertion (þ6 bp) within the homopolymeric stretch. The study identified one schizophrenic with a 13 alanine deletion, but the patient was unavailable for ophthalmologic examination.
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For detecting mutations in PMX2B, an initial screen was performed on the coding region, flanking introns and promoter sequences (130 bp upstream from the reported 5 0 end of exon 1) (15), using the same samples as in ARIX. To identify single nucleotide polymorphisms (SNPs) for use in linkage disequilibrium analysis, we analyzed a region up to 2204 bp upstream from the 5 0 start of the gene, introns 1 and 2 and 1913 bp downstream from the 3 0 end, by examining 30 additional Figure 5 . Effect of c.762A>C polymorphism on aberrant mobility shift in a denaturing gel. Ala20 templates with a c.762C migrate at a À3 base position in the absence of 7-deaza-2 0 -deoxyguanosine triphosphate (c 7 dGTP). This aberrant À3 base allele peak was removed on the addition of c 7 dGTP to the PCR reaction mixture (A). Without c 7 dGTP, 17% of total non-deletion/insertion alleles displayed the À3 base migration. Diagram of sequences (anti-sense strands) shows the c.762A>C polymorphism (B). Secondary structure of the DNA fragment spanning the Ala20 portion was predicted using GENETYX-MAC version 11 software (GENETYX Corporation, Tokyo, Japan) (C). Minimum free energy generated by the secondary structure was À78.3 kcal/mol for the fragment with c.762A and À83.5 kcal/mol for the fragment with c.762C. The fragment with c.762C was deemed to retain at least partial secondary structure even under denaturing conditions. This remnant secondary structure is apparently destroyed when the fragment is PCR-amplified in a reaction mixture containing c samples. Information on primer sequences used in this study is available on request.
Genotyping of PMX2B polymorphisms
The genomic region encoding the 20 alanine (Ala20) tract was amplified using fluorescently labeled forward primer (5 0 -AACCCGGCAAGGGCGGCGCAGCA, 3 0 end at nt c.726) and reverse primer (5 0 -GAAGGGACCCCCAAGCGAAT, 3 0 end at nt c.854), rTaq polymerase (Takara, Tokyo, Japan) and MasterAmp K buffer (Epicentre Technologies, Madison, WI). To avoid artefactual À3 base shifts seen in templates with c.762C, we added 0.2 mM of 7-deaza-2 0 -deoxyguanosine triphosphate (c 7 dGTP) to PCR reaction mixtures (Fig. 5) . PCR products were run on an ABI 3700 genetic analyzer and the resulting data analyzed using GeneScan and Genotyper software (Applied Biosystems, Foster City, CA). Genotypes of mutants were verified using both direct sequencing and subcloning of amplicons into a TA vector (Invitrogen, Carlsbad, CA) and sequencing. Sequencing was performed using a DYEnamic ET terminator cycle sequencing kit (Amersham Biosciences, Piscataway, NJ). TaqMan assay was used to type SNP markers (Applied Biosystems). The mouse Ala20 tract of Pmx2b was examined in 120 C57BL/6 mice, 120 C3H/He mice and 120 of the F1 progeny, using the forward primer (5 0 -AGGCGAACCCGGCAAGGGCGGT, 3 0 end at nt c.657) and reverse primer (5 0 -GAAGGGCCCCCCAAGA GAATCT, 3 0 end at c.789).
Constructs for luciferase assay
The coding region of PMX2B (accession no. NM_003924) was amplified using Human Brain Marathon-Ready cDNA as a template (Clontech, Palo Alto, CA), then cloned into pIRES-neo2 expression vector (Clontech). Altered Ala20 length constructs were prepared by swapping the Ala20 region with those amplified from mutant genomic DNA or using PCR-based techniques (40) . The gene promoter for dopamine b-hydroxylase (DBH) (41) was amplified using a primer set designed from the genomic sequence (accession no. AC001227), then cloned into the pGL3-basic reporter vector (Promega, Madison, WI). Constructs lacking the entire Ala20 and Ala9 regions were generated using PCR-based techniques (40) .
Transfection and luciferase assay
HepG2 cells were purchased from the Riken Cell Bank (Tsukuba, Japan). The plasmid mixture was prepared by combining 1.3 mg of construct DNA (pIRES-neo2-PMX2B : pGL3-basic-DBH promoter ¼ 400 mg : 900 mg), 100 mg of pRL-TK as an internal control and 2.5 ml of LipofectAMINE2000 in 100 ml of OPTI-MEM (Invitrogen). Transfections were performed using Lipofect AMINE2000 (Invitrogen) according to the instructions of the manufacturer. Transcriptional assay was performed using the PicaGene Dual SeaPansy kit in accordance with the manufacturer's instructions (Toyo Ink, Tokyo, Japan). Luciferase activity was measured using a luminometer Lumat LB 9507 (EG&G Berthold, Bad Wildbad, Germany).
Statistical analyses
Phenotype-genotype association tests were assessed using the w 2 test, or Fisher's exact test where appropriate. Linkage disequilibrium (LD) statistics were calculated using COCAPHASE (42) (http://www.hgmp.mrc.ac.uk/$fdudbrid/software/), and estimation of haplotype frequencies and assessment of Hardy-Weinberg equilibrium were performed using Arlequin software (http://lgb.unige.ch/arlequin/). Genotype data from 100 males and 100 females were used for LD and haplotype analyses.
CLUSTALW (program for multiple alignments and treemaking; http://www.ddbj.nig.ac.jp/E-mail/clustalw-e.html) (43) and TreeView ver.1.6.6 (program for displaying phylogenies; http://taxonomy.zoology.gla.ac.uk/rod/treeview.html) (44) software Figure 6 . Functional consequences of PMX2B mutant alleles. Preparation of PMX2B deletion/insertion mutants is shown (A). A, alanine. Effects of Ala20 and Ala9 stretch deletions were examined under luciferase assay. Reporter constructs containing the DBH promoter were co-transfected into HepG2 cells with either normal PMX2B or deletion mutants. Luciferase activity of each construct was normalized by the internal control, pRL-TK. Activity of the normal PMX2B was defined as 1.
Results shown represent meansAE SEM for at least three separate transfections, each run in triplicate. pGL3-basic is a promotorless negative control vector. *P < 0.01 by Tukey-Kramer multiple comparison test (B). Assay of Ala20 mutants was performed under the same conditions as in B (C). *P < 0.01 by Tukey-Kramer test. (squared correlation coefficient). The polymorphisms used in this linkage disequlibrium analysis (SNPs1-6) were those whose minor allele frequencies were more than 3% (also see Fig. 1 ). The Ala20 stretch is located between SNP4 and SNP5.
was used to depict the evolutionary history of haplotypes in a phylogram. Power analysis was performed using the Genetic Power Calculator (http://stagen.iop.kcl.ac.uk/gpc/) (45) .
